Product Code: IRTNTR4885
About Active Pharmaceutical Ingredients
Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.
TechNavio's analysts forecast the Global Active Pharmaceutical Ingredients market to grow at a CAGR of 7.48 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Active Pharmaceutical Ingredients market during the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of active pharmaceutical ingredients by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top seven vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process, type of product, type of player, and geography.
In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, the Global Active Pharmaceutical Ingredients Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
Key Regions
Key Vendors
- Aurobindo Pharma
- BASF
- Boehringer Ingelheim
- Cipla
- Dr. Reddy's Laboratories
- Lonza Group
- Teva Pharmaceutical Industries
Other Prominent Vendors
- Abbott Laboratories
- Actavis
- Aesica
- Albemarle
- AMPAC Fine Chemicals
- Anhui Biochem United Pharmaceutical
- Anuh Pharma
- Aptuit
- AstraZeneca
- Biocon
- Bristol-Myers Squibb
- Calyx Chemicals & Pharmaceuticals
- Cambrex
- Cilag
- CIRON Drugs and Pharmaceuticals
- CTX Life Sciences
- Dishman Pharmaceuticals & Chemicals
- Dr. Paul Lohmann
- Emcure Pharmaceuticals
- Farmabios
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Guilin Pharmaceutical
- Hetero Drugs
- Hospira
- Ipca Laboratories
- Janssen Pharmaceutica
- Johnson Matthey
- Laurus Labs
- Lupin
- Mallinckrodt Pharmaceuticals
- Mangalam Drugs & Organics
- Merck
- Mylan
- Novartis
- Novasep
- Pen Tsao Chemical Industry
- Pfizer
- Ranbaxy Laboratories
- Royal DSM
- Sanofi-Aventis
- Sequent Scientific
- Shanghai Desano Chemical Pharmaceutical
- Shasun
- Shijiazhuang Lonzeal Pharmaceuticals
- Sigma-Aldrich
- ST Pharm
- Sun Pharmaceutical Industries
- WuXi AppTec
- Zhejiang Langhua Pharmaceutical
- Zhuhai Rundu Pharmaceutical
Market Driver
- Increase in Outsourcing Activities
- For a full, detailed list, view our report
Market Challenge
- Decrease in R&D Spending
- For a full, detailed list, view our report
Market Trend
- Emergence of Africa
- For a full, detailed list, view our report
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
- 03.1. Market Overview
- 03.2. Product Offerings
04. Market Research Methodology
- 04.1. Market Research Process
- 04.2. Research Methodology
05. Introduction
06. Market Landscape
07. Global Active Pharmaceutical Ingredients Market
- 07.1. Market Size and Forecast
- 07.2. Five Forces Analysis
08. Market Segmentation by Type of Production Process
- 08.1. Global Market for Synthetically Produced Active Pharmaceutical Ingredients
- 08.1.1. Market Size and Forecast
- 08.2. Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients
- 08.2.1. Market Size and Forecast
- 08.2.2. Market Segmentation by Type of Product
09. Market Segmentation by Type of Product
- 09.1. Global High-potency Active Pharmaceutical Ingredients Market
- 09.1.1. Market Size and Forecast
- 09.1.2. Market Segmentation by Type of Production Process
- 09.1.3. Market Segmentation by Type of Product
10. Market Segmentation by Type of Player
- 10.1. Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product
11. Geographical Segmentation
- 11.1. Active Pharmaceutical Ingredients Market in Americas
- 11.1.1. Market Size and Forecast
- 11.2. Active Pharmaceutical Ingredients Market in APAC Region
- 11.2.1. Market Size and Forecast
- 11.3. Active Pharmaceutical Ingredients Market in EMEA Region
- 11.3.1. Market Size and Forecast
12. Key Leading Countries
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
- 20.1. Competitive Scenario
- 20.2. Key Vendors 2014
- 20.3. Other Prominent Vendors
- 20.3.1. Abbott Laboratories
- 20.3.2. Actavis
- 20.3.3. Aesica
- 20.3.4. Albemarle
- 20.3.5. AMPAC Fine Chemicals
- 20.3.6. Anhui Biochem United Pharmaceutical
- 20.3.7. Anuh Pharma
- 20.3.8. Aptuit
- 20.3.9. AstraZeneca
- 20.3.10. Biocon
- 20.3.11. Bristol-Myers Squibb
- 20.3.12. Calyx Chemicals & Pharmaceuticals
- 20.3.13. Cambrex
- 20.3.14. Cilag
- 20.3.15. CIRON Drugs and Pharmaceuticals
- 20.3.16. CTX Life Sciences
- 20.3.17. Dishman Pharmaceuticals & Chemicals
- 20.3.18. Dr. Paul Lohmann
- 20.3.19. Emcure Pharmaceuticals
- 20.3.20. Farmabios
- 20.3.21. F. Hoffmann-La Roche
- 20.3.22. GlaxoSmithKline
- 20.3.23. Guilin Pharmaceutical
- 20.3.24. Hetero Drugs
- 20.3.25. Hospira
- 20.3.26. Ipca Laboratories
- 20.3.27. Janssen Pharmaceutica
- 20.3.28. Johnson Matthey
- 20.3.29. Laurus Labs
- 20.3.30. Lupin
- 20.3.31. Mallinckrodt Pharmaceuticals
- 20.3.32. Mangalam Drugs & Organics
- 20.3.33. Merck
- 20.3.34. Mylan
- 20.3.35. Novartis
- 20.3.36. Novasep
- 20.3.37. Pen Tsao Chemical Industry
- 20.3.38. Pfizer
- 20.3.39. Ranbaxy Laboratories
- 20.3.40. Royal DSM
- 20.3.41. Sanofi-Aventis
- 20.3.42. Sequent Scientific
- 20.3.43. Shanghai Desano Chemical Pharmaceutical
- 20.3.44. Shasun
- 20.3.45. Shijiazhuang Lonzeal Pharmaceuticals
- 20.3.46. Sigma-Aldrich
- 20.3.47. ST Pharm
- 20.3.48. Sun Pharmaceutical Industries
- 20.3.49. WuXi AppTec
- 20.3.50. Zhejiang Langhua Pharmaceutical
- 20.3.51. Zhuhai Rundu Pharmaceutical
21. Key Vendor Analysis
- 21.1. Aurobindo Pharma
- 21.1.1. Key Facts
- 21.1.2. Business Overview
- 21.1.3. Business Segmentation
- 21.1.4. Geographical Segmentation by Revenue 2014
- 21.1.5. Business Strategy
- 21.1.6. Recent Developments
- 21.1.7. SWOT Analysis
- 21.2. BASF
- 21.2.1. Key Facts
- 21.2.2. Business Overview
- 21.2.3. Business/Product Segmentation
- 21.2.4. Business Segmentation by Revenue 2012 and 2013
- 21.2.5. Geographical Segmentation by Revenue 2013
- 21.2.6. Business Strategy
- 21.2.7. Recent Developments
- 21.2.8. SWOT Analysis
- 21.3. Boehringer Ingelheim
- 21.3.1. Key Facts
- 21.3.2. Business Overview
- 21.3.3. Business Segmentation by Revenue 2013
- 21.3.4. Business Segmentation by Revenue 2012 and 2013
- 21.3.5. Geographical Segmentation by Revenue 2013
- 21.3.6. Business Strategy
- 21.3.7. Recent Developments
- 21.3.8. SWOT Analysis
- 21.4. Cipla
- 21.4.1. Key Facts
- 21.4.2. Business Overview
- 21.4.3. Product Segmentation
- 21.4.4. Geographical Segmentation by Revenue 2014
- 21.4.5. Business Strategy
- 21.4.6. Recent Developments
- 21.4.7. SWOT Analysis
- 21.5. Dr. Reddy's Laboratories
- 21.5.1. Key Facts
- 21.5.2. Business Overview
- 21.5.3. Business Segmentation by Revenue 2014
- 21.5.4. Business Segmentation by Revenue 2013 and 2014
- 21.5.5. Geographical Segmentation by Revenue 2014
- 21.5.6. Business Strategy
- 21.5.7. Recent Developments
- 21.5.8. SWOT Analysis
- 21.6. Lonza Group
- 21.6.1. Key Facts
- 21.6.2. Business Overview
- 21.6.3. Business Segmentation by Revenue 2013
- 21.6.4. Business Segmentation by Revenue 2012 and 2013
- 21.6.5. Geographical Segmentation by Revenue 2013
- 21.6.6. Business Strategy
- 21.6.7. Recent Developments
- 21.6.8. SWOT Analysis
- 21.7. Teva Pharmaceutical Industries
- 21.7.1. Key Facts
- 21.7.2. Business Overview
- 21.7.3. Business Segmentation
- 21.7.4. Business Segmentation by Revenue 2013
- 21.7.5. Business Segmentation by Revenue 2012 and 2013
- 21.7.6. Sales by Geography
- 21.7.7. Business Strategy
- 21.7.8. Key Developments
- 21.7.9. SWOT Analysis
22. Other Reports in this Series
List of Exhibits
- Exhibit 1: Market Research Methodology
- Exhibit 2: Global Active Pharmaceutical Ingredients Market Segmentation
- Exhibit 3: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process
- Exhibit 4: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product
- Exhibit 5: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player
- Exhibit 6: Global Active Pharmaceutical Ingredients Market Segmentation by Geography
- Exhibit 7: Global Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
- Exhibit 8: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
- Exhibit 9: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014-2019
- Exhibit 10: Global Market for Synthetically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
- Exhibit 11: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
- Exhibit 12: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients: Segmentation by Type of Product 2014
- Exhibit 13: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
- Exhibit 14: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014-2019
- Exhibit 15: Global High-potency Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
- Exhibit 16: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
- Exhibit 17: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
- Exhibit 18: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player 2014
- Exhibit 19: Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
- Exhibit 20: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014
- Exhibit 21: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014-2019
- Exhibit 22: Active Pharmaceutical Ingredients Market in Americas 2014-2019 (US$ billion)
- Exhibit 23: Active Pharmaceutical Ingredients Market in Americas: Segmentation by Key Leading Country 2014
- Exhibit 24: Active Pharmaceutical Ingredients Market in APAC Region 2014-2019 (US$ billion)
- Exhibit 25: Active Pharmaceutical Ingredients Market in APAC Region: Segmentation by Key Leading Country 2014
- Exhibit 26: Active Pharmaceutical Ingredients Market in EMEA Region 2014-2019 (US$ billion)
- Exhibit 27: Active Pharmaceutical Ingredients Market in EMEA Region: Segmentation by Key Leading Countries 2014
- Exhibit 28: Global Active Pharmaceutical Ingredients Market: Key Leading Countries 2014
- Exhibit 29: WHO's List of Prequalified Active Pharmaceutical Ingredients (22nd October, 2014)
- Exhibit 30: Aurobindo Pharma: Business Segmentation
- Exhibit 31: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
- Exhibit 32: BASF: Business Segmentation 2013
- Exhibit 33: BASF: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
- Exhibit 34: BASF: Geographical Segmentation by Revenue 2013
- Exhibit 35: Boehringer Ingelheim: Business Segmentation by Revenue 2013
- Exhibit 36: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
- Exhibit 37: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
- Exhibit 38: Cipla: Product Segmentation
- Exhibit 39: Cipla: Geographical Segmentation by Revenue 2014
- Exhibit 40: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2014
- Exhibit 41: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
- Exhibit 42: Dr. Reddy's Laboratories: Geographical Segmentation by Revenue 2014
- Exhibit 43: Lonza Group: Business Segmentation by Revenue 2013
- Exhibit 44: Lonza Group: Business Segmentation by Revenue 2012 and 2013 (US$ million)
- Exhibit 45: Lonza Group: Geographical Segmentation by Revenue 2013
- Exhibit 46: Teva Pharmaceutical Industries: Business Segmentation
- Exhibit 47: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
- Exhibit 48: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
- Exhibit 49: Teva Pharmaceutical Industries: Sales by Geography 2013
